<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>TMX Newsfile News Releases (InvestorIdeas) [cannabis]</title>
		<link>https://feeds.newsfilecorp.com/feed/InvestorIdeas/cannabis</link>
		<description>Latest news releases from TMX Newsfile, customized for InvestorIdeas.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Sun, 15 Mar 2026 13:25:09 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/tmx-newsfile-wire-logo.png</url>
			<title>TMX Newsfile News Releases (InvestorIdeas) [cannabis]</title>
			<link>https://feeds.newsfilecorp.com/feed/InvestorIdeas/cannabis</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/feed/InvestorIdeas/cannabis"/>
		<item xml:lang="en">
			<title>Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures</title>
			<link>https://www.newsfilecorp.com/release/288344/Digicann-Ventures-Announces-Agreement-to-Extend-Maturity-Date-for-Convertible-Debentures</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/288344/273" id="273" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, announces that it has entered into an agreement with holders of the Company's 10.00% Senior Unsecured Convertible Debentures (the "Debentures") to amend the Debentures to extend the maturity date for an additional twelve months from March 12, 2026 to March 12, 2027. The Company has...</description>
			<pubDate>Thu, 12 Mar 2026 17:01:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/stocksymbol">CNSX:DCNN.X</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">ISIN:CA25380E1060</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/288344</guid>
		</item>
		<item xml:lang="en">
			<title>Psyched Wellness Announces Private Placement for Proceeds of up to C$1,719,306.94</title>
			<link>https://www.newsfilecorp.com/release/288102/Psyched-Wellness-Announces-Private-Placement-for-Proceeds-of-up-to-C1719306.94</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/288102/273" id="273" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Toronto, Ontario--(Newsfile Corp. - March 11, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is excited to announce that it has entered into a non-binding memorandum of terms (the "Term Sheet") with Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together, "Gotham Green")...</description>
			<pubDate>Wed, 11 Mar 2026 08:54:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/stocksymbol">CNSX:PSYC</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">FSE:5U9</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">ISIN:CA74447P1009</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/288102</guid>
		</item>
		<item xml:lang="en">
			<title>RETRANSMISSION: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation</title>
			<link>https://www.newsfilecorp.com/release/288047/RETRANSMISSION-Red-Light-Holland-Signs-Definitive-Agreement-with-Filament-Health-to-Expand-Its-Platform-for-Natural-Psychedelic-Drug-Development-and-Microdosing-Innovation</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/288047/273" id="273" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering natural psilocybin manufacturing and formulationCombines Red Light's operational scale, global brand presence, and real-world microdosing data with Filament's pharmaceutical R&amp;D capabilities and patented PEX010 botanical psilocybin drug candidateAll-share transaction in which existing Red Light...</description>
			<pubDate>Wed, 11 Mar 2026 07:30:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/stocksymbol">OTCQB:TRUFF</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">CNSX:TRIP</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">FSE:4YX</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">ISIN:CA75671E1097</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/288047</guid>
		</item>
		<item xml:lang="en">
			<title>Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation</title>
			<link>https://www.newsfilecorp.com/release/288032/Red-Light-Holland-Signs-Definitive-Agreement-with-Filament-Health-to-Expand-Its-Platform-for-Natural-Psychedelic-Drug-Development-and-Microdosing-Innovation</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/288032/273" id="273" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering natural psilocybin manufacturing and formulationCombines Red Light's operational scale, global brand presence, and real-world microdosing data with Filament's pharmaceutical R&amp;D capabilities and patented PEX010 botanical psilocybin drug candidateAll-share transaction in which existing Red Light...</description>
			<pubDate>Tue, 10 Mar 2026 16:40:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/stocksymbol">OTCQB:TRUFF</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">CNSX:TRIP</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">FSE:4YX</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">ISIN:CA75671E1097</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/288032</guid>
		</item>
		<item xml:lang="en">
			<title>Stock Trend Capital Provides Younet AI Investment Update</title>
			<link>https://www.newsfilecorp.com/release/287691/Stock-Trend-Capital-Provides-Younet-AI-Investment-Update</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/287691/273" id="273" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - March 9, 2026) - Stock Trend Capital Inc. (CSE: STCQ) (FSE: P0G) (OTC Pink: STOCF) (the "Company" or "Stock Trend") is pleased to provide shareholders with an update regarding its investment in Younet AI ("Younet"), a privately held Canadian company developing artificial-intelligence platforms and tools enabling users to build customized AI models trained on their own data to automate tasks, enhance productivity, and improve workflows and...</description>
			<pubDate>Mon, 09 Mar 2026 06:20:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/stocksymbol">OTC PINK:STOCF</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">CNSX:STCQ</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">FSE:P0G</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">ISIN:CA86102Q1081</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/287691</guid>
		</item>
		<item xml:lang="en">
			<title>Vext Advances Ohio Expansion with Seventh Retail Location</title>
			<link>https://www.newsfilecorp.com/release/286113/Vext-Advances-Ohio-Expansion-with-Seventh-Retail-Location</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/286113/273" id="273" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Secures provisional dual-use license for Columbus dispensary, with operations expected to begin in Q4 2026, subject to regulatory approvals.Marks Vext's seventh dispensary in Ohio, and second in Columbus, as the Company advances toward the state's eight-store cap.Scales vertically integrated footprint in Ohio, positioning Vext to drive operating leverage and cash flow growth as additional retail locations come online and stabilize.Vancouver, British Columbia--(Newsfile Corp. - March 3, 2026) -...</description>
			<pubDate>Tue, 03 Mar 2026 17:00:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/stocksymbol">OTCQX:VEXTF</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">CNSX:VEXT</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">FSE:VV5</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">ISIN:CA9255401064</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/286113</guid>
		</item>
		<item xml:lang="en">
			<title>Nextleaf Solutions Reports Profitable Q1 FY26 with Revenue Growth and Positive Operating Cash Flow</title>
			<link>https://www.newsfilecorp.com/release/286099/Nextleaf-Solutions-Reports-Profitable-Q1-FY26-with-Revenue-Growth-and-Positive-Operating-Cash-Flow</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/286099/273" id="273" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - March 3, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor announced today its financial results for the three months ended December 31, 2025 ("Q1 FY26") reporting gross revenue of CAD $3,994,369, net revenue of CAD $3,020,519, and gross profit of CAD $1,288,197.Q1 FY26 marked continued execution, with sustained...</description>
			<pubDate>Tue, 03 Mar 2026 08:59:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/stocksymbol">OTCQB:OILFF</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">CNSX:OILS</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">FSE:L0MA</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">ISIN:CA65347A1021</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/286099</guid>
		</item>
		<item xml:lang="en">
			<title>Red Light Holland Reports Third Quarter 2026 Results and Provides Corporate Update</title>
			<link>https://www.newsfilecorp.com/release/286088/Red-Light-Holland-Reports-Third-Quarter-2026-Results-and-Provides-Corporate-Update</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/286088/273" id="273" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Toronto, Ontario--(Newsfile Corp. - March 3, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based organization advancing a focused strategy within the legal psychedelic sector, centered on consensual data collection and research and development ("R&amp;D") initiatives designed to expand naturally occurring drug development, understanding of psilocybin use and consumer experiences, which in parallel, operates commercial...</description>
			<pubDate>Tue, 03 Mar 2026 08:00:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/stocksymbol">OTCQB:TRUFF</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">CNSX:TRIP</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">FSE:4YX</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">ISIN:CA75671E1097</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/286088</guid>
		</item>
		<item xml:lang="en">
			<title>Delota Reports Financial Results for the Three and Nine Months Ended December 31, 2025</title>
			<link>https://www.newsfilecorp.com/release/286015/Delota-Reports-Financial-Results-for-the-Three-and-Nine-Months-Ended-December-31-2025</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/286015/273" id="273" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;HighlightsTotal revenue of $8.4 million for Q3 2026Total System-Wide Revenue of $10.0 million for Q3 2026 30% gross profit margin for Q3 2026Total revenue of $27.1 million for the Nine Months Ended 2026Total System-Wide Revenue of $30.9 million for the Nine Months Ended 202633% gross profit margin for the Nine Months Ended 2026Segmented revenue for the Nine Months Ended 2026: Vape - B2C: $16.4 million, B2B: $7.8 millionCannabis - B2C: $2.9 millionCustomer base of over 350,000 registered accounts...</description>
			<pubDate>Tue, 03 Mar 2026 07:30:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/stocksymbol">OTC PINK:SYDRF</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">CNSX:NIC</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">FSE:S62</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">ISIN:CA24713H1001</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/286015</guid>
		</item>
		<item xml:lang="en">
			<title>Adastra Holdings Announces Agreement to Sell Assets and Resignation of Director</title>
			<link>https://www.newsfilecorp.com/release/285873/Adastra-Holdings-Announces-Agreement-to-Sell-Assets-and-Resignation-of-Director</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/285873/273" id="273" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Langley, British Columbia--(Newsfile Corp. - March 2, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) ("Adastra" or the "Company") announces that Adastra Labs Inc. ("Adastra Labs"), a wholly-owned subsidiary of the Company, has entered into an asset purchase agreement dated February 27, 2026 with an arm's length purchaser (the "Purchaser"), pursuant to which Adastra Labs has agreed to sell certain cryoethanol and hydrocarbon extraction and processing equipment as well as packaging and...</description>
			<pubDate>Mon, 02 Mar 2026 08:30:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/stocksymbol">OTC PINK:XTXXF</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">CNSX:XTRX</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">FSE:D2E0</category>
			<category domain="https://www.newsfilecorp.com/stocksymbol">ISIN:CA00654D1006</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/285873</guid>
		</item>
	</channel>
</rss>
